Investors considering a purchase of Arbutus Biopharma Corp (ABUS) stock, but cautious about paying the going market price of $2.56/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $2 strike, which has a bid at the time of this writing of 20 cents..